Skip to contentSkip to filters

We use cookies for analytics.

Topic: phosphorylated tau

Seminar
1 seminar

In Biochemistry and Biology

Seminar · Clinical Neurology

Blood phosphorylated tau as biomarkers for Alzheimer’s disease

Thomas K. Karikari · University of Gothenburg

Thu, Dec 10, 2020 · 15:00 UTC

Alzheimer's disease (AD) is the most common cause of dementia, and its health and socioeconomic burdens are of major concern. Presently, a definite diagnosis of AD is established by examining brain tissue after death. These examinations focus on two major pathological hallmarks of AD in the brain: (i) amyloid plaques consisting of aggregated amyloid beta (Aβ) peptides and (ii) neurofibrillary tangles made of abnormally phosphorylated tau protein. In living individuals, AD diagnosis relies on two main approaches: (i) brain imaging of tau tangles and Aβ plaques using a technique called positron